2John C,Byrd, Krzysztof Mro′zek,Richard K.Dodge,et al.Pretreatment cytogenetic abnormalities are predictive of induc-tion success,cumulative incidence of relapse,and over-all sur-vival in adult patients with de novo acute myeloid leukemia:results from Cancer and Leukemia Group B(CALGB 8461)[J].Blood, 2002,100(13):4 325-4 336.
3David Grimwade,Helen Walker,Fiona Oliver,et al.The Importance of Diagnostic Cytogenetics on Outcome in AML:Analysis of 1,612 Patients Entered Into the MRC AML 10 Tr-ial[J].Blood,1998,92(7):2 322-2 333.
4Marilyn L,Slovak,Kenneth J.Kopey,Peter A.Cassileth,et al.Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia:a So-uthwest Oncology Group/Eastern Cooperative Oncology Grou-p study[J].Blood,2000,96(13):4 075-4 083.
7Daniela Diverio,Vincenzo Rossi,Giuseppe Avvisati,et al.Early Detection of Relapse by Prospective Reverse Transcr-iptase-Polymerase Chain Reaction Analysis of the PML/RARα Fusion Gene in Patients With Acute Promyelocytic Le-ukemia Enrolled in the GIMEMA-AIEOP Multicenter "AIDA" Trial[J].Blood,1998,92(3):784-789.
8Susana C.Raimondi,Myron N.Chang,Yaddanapudi Ravi-ndranath,et al.Chromosomal Abnormalities in 478 Children With Acute Myeloid Leukemia:Clinical Characteristics and Treatment Outcome in a Cooperative Pediatric OncologyGro-up Study-POG 8821[J].Blood,1999,94(11):3 707-3 716.
9Claudia Schoch,Susanne Schnittger,Mirjam Klaus,et al.AML with 11q23/MLL abnormalities as defined by the WH O classification: incidence,partner chromosomes,FAB subt-ype,age distribution,and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases[J].Blood,2003,102(7):2 395-2 402.
